Trending Topic

Thyroid gland inside human body. 3D illustration
5 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Thyroid eye disease (TED), also known as Graves’ orbitopathy, is a complex autoimmune disorder driven by an interplay of immune cells, orbital fibroblasts and tissue remodelling factors that lead to inflammation, oedema and, ultimately, potential vision loss.1 While the disease has historically been challenging to manage, recent therapeutic innovations are reshaping treatment paradigms and offering new […]

Cardiovascular Risk

An Introduction to Cardiovascular Risk

Sponsored Content

Watch experts discuss the risk assessment and management of heart failure in diabetes, with insights into epidemiology, screening and treatment strategies.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.

Mark CompleteCompleted
BookmarkBookmarked

What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.

33 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchPANEL DISCUSSION
Dr Barbara Burton, Dr Christina Lampe, Dr Can Ficicioglu

Experts discuss optimization of multidisciplinary care of alpha-mannosidosis along the patient’s lifespan.

Sponsored Content
touchINFOGRAPHIC
For HCPs in: Europe

Learn about barriers to effective long-term weight management and pharmacological treatment options for obesity.

6 mins
Sponsored Content

Watch a leading expert discuss the need for personalised obesity treatment including current evidence for cardiovascular outcomes.

Mark CompleteCompleted
BookmarkBookmarked

touchENDOCRINOLOGY was delighted to speak with Editorial Board member Dr Deep Dutta, a senior endocrinologist at the CEDAR Superspecialty Clinics, New Delhi, India. Throughout this interview, he summarizes the key messages from his late-breaking abstract session ‘Ailing Heart, Broken Vessels’, presented at the 60th European Association for the Study of Diabetes (EASD) annual meeting in Madrid, Spain.

Mark CompleteCompleted
BookmarkBookmarked
Cornelius J Fernandez, Lakshmi Nagendra, Mohammed Alkhalifah

Hypertension affects up to 40% of the adult population worldwide,1 and according to the World Health Organization’s 2021 estimates, globally 1.28 billion adults between 18 and 79 years are affected.2 Of these, 85% have essential hypertension3 and the remainder have secondary hypertension, which is potentially ...

Developed by Touch
Coverage from: ADA Highlights

Dr. Carolina Solis-Herrera (Associate Professor of Medicine at the University of Texas Health San Antonio (UTHSA) and Chief of Endocrinology Division) provides an overview of their presentation: Empagliflozin Improves Cardiopulmonary Function and VE/VCO2 in Patients with T2D and ...

Developed by Touch
Coverage from: ADA Highlights

The CLEAR Outcomes trial was a double-blind, randomized, placebo-controlled trial involving patients who were “statin-intolerant” and had, or were at high risk for, cardiovascular disease. The patients were assigned to receive oral bempedoic acid, 180 mg daily, or placebo. Dr. Steven ...

Mark CompleteCompleted
BookmarkBookmarked
Mohammad S Jeeyavudeen, Joseph M Pappachan, Ganesan Arunagirinathan

In the early 1970s, the discovery of statin by Dr Akira Endo changed the fate of cardiovascular disease prevention and the treatment of atherosclerosis. It was during this period that the rate-limiting step in cholesterol biosynthesis was revealed, and the ...

Mark CompleteCompleted
BookmarkBookmarked

Chylomicronaemia refers to the pathological presence of large, circulating, intestinally derived chylomicrons.1 Clinical features of chylomicronaemia syndrome include lipaemic plasma, lipaemia retinalis, eruptive xanthomas, hepatosplenomegaly, neurological symptoms such as mental fog and mood changes and, most importantly, increased risk of ...

38 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

Watch experts in endocrinology and in primary care discuss key considerations for addressing cardiorenal outcomes in patients with CKD/T2D

Developed by Touch
Coverage from: EASD Highlights

Diabetes increases the risk of cardiovascular (CV) and renal disease (CVRD). These become major causes of mortality in individuals with diabetes. In this touchENDOCRINOLOGY interview, Prof. Peter Rossing (University of Copenhagen, Copenhagen, Denmark) discusses the relationship between cardiovascular and renal ...

Developed by Touch
Coverage from: EASD Highlights

SUSTAIN 6 and PIONEER 6 investigated the effects of semaglutide versus placebo on major adverse cardiovascular events (MACE). The current post hoc analysis investigated the association between baseline kidney function and risk of MACE, and the effect of semaglutide on risk of ...

Developed by Touch
Coverage from: ADA Highlights

The ELIXA biomarker study evaluated protein biomarkers as clinical risk factors to identify people with type 2 diabetes and acute coronary syndrome who are at highest risk for cardiovascular (CV) outcomes and death. Professor Hertzel Gerstein (McMaster University, Hamilton, ON, Canada) ...

Developed by Touch
Coverage from: ADA Highlights

The clinical risk factors for cardiovascular disease in patients with type 2 diabetes and the link between the two is discussed by Professor Hertzel Gerstein (McMaster University, Hamilton, ON, Canada). Professor Hertzel Gerstein presented an abstract entitled ‘Cardiovascular Outcomes in People ...

37 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchMDT
Prof. Carol Wysham, Dr Ken Fujioka, Ms Jennifer Okemah, Patient: Ms. Brittany Jones

Watch specialists within an MDT plus a patient discuss incretin-based dual agonists and educational strategies for patients with T2D and obesity

Load More...
Close Popup